Media Highlights
Adding Isatuximab to Standard Backbone Improves Outcomes in Multiple Myeloma
June 04, 2024
Dr. Ola Landgren discusses the benefits of immunotherapy on newly diagnosed multiple myeloma patients, regardless of transplant eligibility.
Tags: C. Ola Landgren, Sylvester Comprehensive Cancer Center
